Evidence map›Paper›PMID 23878099›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2013

Copper-catalyzed oxidative amination and allylic amination of alkenes.

Timothy W Liwosz, Sherry R Chemler

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Copper-catalyzed generation of nitrogen-centered radicals and reactions thereof.ARKIVOC : free online journal of organic chemistry · 2024
    Article
  3. Copper-Catalyzed Intramolecular Olefinic C(spMolecules (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Chemical Space Exploration of Oxetanes.International journal of molecular sciences · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Recent advances in copper-catalyzed C-H bond amidation.Beilstein journal of organic chemistry · 2015
    Review
  11. Article
  12. Article
  13. Copper-Catalyzed Synthesis ofSynlett : accounts and rapid communications in synthetic organic chemistry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timothy W LiwoszDepartment of Chemistry, The State University of New York at Buffalo, Buffalo, NY 14260 (USA), Fax: (+1) 716-645-6963.
Sherry R Chemler

Funding

New Methods for Nitrogen Heterocycle SynthesisR01GM078383 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CHEMLER, SHERRY R · 2006 to 2023
$5.6M
NIGMS NIH HHS GM-078383NIGMS NIH HHS R01 GM078383
6 · The paper itself

Abstract

Enamines and enamides are useful synthetic intermediates and common components of bioactive compounds. A new protocol for their direct synthesis by a net alkene C-H amination and allylic amination by using catalytic Cu(II) in the presence of MnO2 is reported. Reactions between N-aryl sulfonamides and vinyl arenes furnish enamides, allylic amines, indoles, benzothiazine dioxides, and dibenzazepines directly and efficiently. Control experiments further showed that MnO2 alone can promote the reaction in the absence of a copper salt, albeit with lower efficiency. Mechanistic probes support the involvement of nitrogen-radical intermediates. This method is ideal for the synthesis of enamides from 1,1-disubstituted vinyl arenes, which are uncommon substrates in existing oxidative amination protocols.

Indexed as

AlkenesAminationAminesCatalysisCopperIndolesManganese CompoundsOxidation-ReductionOxidesStereoisomerismAlkenesAminesCopperIndolesManganese Compoundsmanganese dioxideOxidesaminationcopperenamidesindolesoxidation

Identifiers

PMID23878099
PMCPMC4038966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.